Kips Bay Medical

Kips Bay Medical, Inc. was founded in 2007 to develop innovative vascular technologies for cardiac surgeons. The company focuses on the development, manufacturing, and commercialization of its external saphenous vein support technology, or eSVS MESH, for use in coronary artery bypass grafting (CABG) procedures.On June 28, 2015, the company's board of directors terminated the company's eMESH I clinical feasibility trial because the results of the company’s new implant technology did not meet the level that the company believed was necessary to advance its U.S. regulatory strategy.On September 22, 2015, the shareholders of Kips Bay Medical approved a voluntary plan of dissolution and liquidation of the company, and on September 24, 2015, the company filed a certificate of dissolution with the Secretary of State of Delaware. Also, on September 24, 2015, the Securities and Exchange Commission suspended the company's reporting requirements, and the company filed a certification and notice of termination of registration.